Carboplatin hypersensitivity: evaluation and successful desensitization protocol

被引:2
作者
Bruchim, Ilan [1 ,2 ]
Goldberg, Arnon [2 ,3 ]
Fishman, Ami [1 ,2 ]
Confino-Cohen, Ronit [2 ,3 ]
机构
[1] Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Meir Med Ctr, Allergy & Clin Immunol Unit, Kefar Sava, Israel
关键词
allergic evaluation; carboplatin allergy; desensitization; ovarian cancer; skin test; PEGYLATED LIPOSOMAL DOXORUBICIN; RAPID DESENSITIZATION; CLINICAL-FEATURES; OVARIAN-CANCER; SKIN-TEST; CHEMOTHERAPY; MALIGNANCIES; COMBINATION; EXPERIENCE; MANAGEMENT;
D O I
10.2217/IMT.14.71
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Carboplatin-induced immediate hypersensitivity reactions are relatively common among patients with gynecological malignancies. Once this occurs, the patient might be at risk for future carboplatin-induced reactions. This study evaluated the efficacy of allergic consultation, carboplatin skin testing and desensitization as a single intervention strategy in this population. Methods: Patients with a well-documented immediate reaction to carboplatin were offered allergy consultation, carboplatin skin testing and a desensitization plan in a single visit between scheduled chemotherapy sessions. Results: Fifty-five patients with an immediate reaction were evaluated. After allergist assessment, 44 (89%) of 49 patients skin tested had a positive result. A total of 207 carboplatin desensitization cycles were administered to 49 women. Among them, 10 patients had a mild immediate hypersensitivity reaction during desensitization. Five patients subsequently tolerated carboplatin administered in the prolonged desensitization protocol. Conclusions: In the data presented, we propose a strategy that is both cost effective and very convenient for the patient. The diagnostic procedure, including allergist consultation and skin test, can be completed in less than 2 h. In most cases where carboplatin is indispensable, desensitization can be administered without overnight hospitalization.
引用
收藏
页码:905 / 912
页数:8
相关论文
共 20 条
[1]   A review of issues surrounding quality of life among women with ovarian cancer [J].
Arriba, Lucybeth Nieves ;
Fader, Amanda Nickles ;
Frasure, Heidi E. ;
von Gruenigen, Vivian E. .
GYNECOLOGIC ONCOLOGY, 2010, 119 (02) :390-396
[2]   Clinical features and severity grading of anaphylaxis [J].
Brown, SGA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (02) :371-376
[3]   Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases [J].
Castells, Mariana C. ;
Tennant, Nichole M. ;
Sloane, David E. ;
Hsu, F. Ida ;
Barrett, Nora A. ;
Hong, David I. ;
Laidlaw, Tanya M. ;
Legere, Henry J. ;
Nallamshetty, Samridhi N. ;
Palis, Ross I. ;
Rao, Jayanti J. ;
Berlin, Suzanne T. ;
Campos, Susana M. ;
Matulonis, Ursula A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :574-580
[4]   Successful carboplatin desensitization in patients with proven carboplatin allergy [J].
Confino-Cohen, R ;
Fishman, A ;
Altaras, M ;
Goldberg, A .
CANCER, 2005, 104 (03) :640-643
[5]  
Gastaminza G, 2011, J INVEST ALLERG CLIN, V21, P108
[6]   A modified, prolonged desensitization protocol in carboplatin allergy [J].
Goldberg, A ;
ConfinoCohen, R ;
Fishman, A ;
Beyth, Y ;
Altaras, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (04) :841-843
[7]   Carboplatin Hypersensitivity Does Introduction of Skin Test and Desensitization Reliably Predict and Avoid the Problem? A Prospective Single-Center Study [J].
Gomez, Ruth ;
Harter, Philipp ;
Lueck, Hans-Joachim ;
Traut, Alexander ;
Kommoss, Stefan ;
Kandel, Michaela ;
du Bois, Andreas .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (07) :1284-1287
[8]   Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine-Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review [J].
Holloway, Robert W. ;
Grendys, Edward C. ;
Lefebvre, Patrick ;
Vekeman, Francis ;
McMeekin, Scott .
ONCOLOGIST, 2010, 15 (10) :1073-1082
[9]   Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial [J].
Joly, Florence ;
Ray-Coquard, Isabelle ;
Fabbro, Michel ;
Donoghoe, Mark ;
Boman, Karin ;
Sugimoto, Akira ;
Vaughan, Michelle ;
Reinthaller, Alexander ;
Vergote, Ignace ;
Ferrandina, Gabriella ;
Dell'Anna, Tiziana ;
Huober, Jens ;
Pujade-Lauraine, Eric .
GYNECOLOGIC ONCOLOGY, 2011, 122 (02) :226-232
[10]   Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions [J].
Lee, CW ;
Matulonis, UA ;
Castells, MC .
GYNECOLOGIC ONCOLOGY, 2004, 95 (02) :370-376